PIA
DOVA

Piedmont Investment Advisors’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Piedmont Investment Advisors’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-205
Closed -$6K – 2790
2018
Q2 		$6K Buy
+205
New +$5.58K ﹤0.01% 2077

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Piedmont Investment Advisors's DOVA Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2018, closing a stake of 205 shares — an estimated $6K sold.

Piedmont Investment Advisors first reported a position in DOVA in Q2 2018 and held it in 1 quarter. The position peaked at $6K in Q2 2018. 63 funds tracked by Wall St. Rank hold DOVA as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 205 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $6K.
  • Piedmont Investment Advisors first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Dova Pharmaceuticals, Inc. Common Stock position peaked at $6K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.